Necroptosis inhibitor necrostatin-1 targeting RIPK1 or siRNA-mediated knockdown of RIPK1 significantly enhanced SHK-induced apoptosis in K562, HL-60, and primary leukemia cells (Han et al., 2012). Here, SHPK is linked to leukemia.